Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rufang Xiang"'
Autor:
Zeyi Li, Peng Jin, Rufang Xiang, Xiaoyang Li, Jie Shen, Mengke He, Xiaxin Liu, Hongming Zhu, Shishuang Wu, Fangyi Dong, Huijin Zhao, Han Liu, Zhen Jin, Junmin Li
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Although advancements in genomic and epigenetic research have deepened our understanding of acute myeloid leukemia (AML), only one-third of patients can achieve durable remission. Growing evidence suggests that the immune microenvironment in bone mar
Externí odkaz:
https://doaj.org/article/ce5bd95534274074ad17b46aa4cd3146
Autor:
Ran Li, Zuoyou Ding, Peng Jin, Shishuang Wu, Ge Jiang, Rufang Xiang, Wenfang Wang, Zhen Jin, Xiaoyang Li, Kai Xue, Xiaolu Wu, Junmin Li
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The prognosis of acute myeloid leukemia (AML) is closely related to immune response changes. Further exploration of the pathobiology of AML focusing on immune-related genes would contribute to the development of more advanced evaluation and treatment
Externí odkaz:
https://doaj.org/article/7aeb035e361c4c3db3e8670853867c8d
Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy
Autor:
Jia Tong, Xiaoguang Xu, Zilu Zhang, Chengning Ma, Rufang Xiang, Jia Liu, Wenbin Xu, Chao Wu, Junmin Li, Fenghuang Zhan, Yingli Wu, Hua Yan
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
Multiple myeloma is a malignant plasma-cell disease, which is highly dependent on the hypoxic bone marrow microenvironment. However, the underlying mechanisms of hypoxia contributing to myeloma genesis are not fully understood. Here, we show that lon
Externí odkaz:
https://doaj.org/article/d13561ff4c604593b8a642147b5390b8
Autor:
Zeyi Li, Peng Jin, Rufang Xiang, Xiaoyang Li, Jie Shen, Mengke He, Xiaxin Liu, Hongming Zhu, Shishuang Wu, Fangyi Dong, Huijin Zhao, Han Liu, Zhen Jin, Junmin Li
Publikováno v:
Frontiers in Immunology; 2024, p1-13, 13p
Publikováno v:
Molecular Carcinogenesis. 62:676-684
Autor:
Zhen Jin, Rufang Xiang, Kai Qing, Dan Li, Zhao Liu, Xiaoyang Li, Hongming Zhu, Yunxiang Zhang, Lining Wang, Kai Xue, Han Liu, Zizhen Xu, Yingxiao Wang, Junmin Li
Purpose:Chimeric antigen receptor (CAR)-T cells against CD19 have been proven to be effective in treating B-cell hematological malignancies. However, the efficacy of this promising therapy is limited by many factors. Methods: In this study, the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104958b1b8da21def46bb3b2bb1aead2
https://doi.org/10.21203/rs.3.rs-2572328/v1
https://doi.org/10.21203/rs.3.rs-2572328/v1
Autor:
Ge Jiang, Shishuang Wu, Ran Li, Hongming Zhu, Junmin Li, Rufang Xiang, Zhen Jin, Xiaoyang Li, Yunxiang Zhang, Wen-Fang Wang, Kai Qing, Lining Wang, Zi-Zhen Xu, Kai Xue
Publikováno v:
Chemotherapy. 67:12-23
Introduction: The chemoresistance mechanism of diffuse large B-cell lymphoma (DLBCL) is still poorly understood, and patient prognosis remains unsatisfactory. This study aimed to investigate drug resistance mechanisms in non-germinal center B-cell-li
Autor:
Ge Jiang, Zuoyou Ding, Shishuang Wu, Zhen Jin, Xiaolu Wu, Ran Li, Kai Xue, Peng Jin, Wen-Fang Wang, Junmin Li, Rufang Xiang, Xiaoyang Li
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
The prognosis of acute myeloid leukemia (AML) is closely related to immune response changes. Further exploration of the pathobiology of AML focusing on immune-related genes would contribute to the development of more advanced evaluation and treatment
Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy
Autor:
Rufang Xiang, Chao Wu, Hua Yan, Zilu Zhang, Ying-Li Wu, Chengning Ma, Junmin Li, Wenbin Xu, Fenghuang Zhan, Jia Tong, Jia Liu, Xiaoguang Xu
Publikováno v:
Haematologica
Multiple myeloma is a malignant plasma-cell disease, which is highly dependent on the hypoxic bone marrow microenvironment. However, the underlying mechanisms of hypoxia contributing to myeloma genesis are not fully understood. Here, we show that lon
Autor:
Rufang Xiang, Yuan-Fei Mao, Kai Qing, Lining Wang, Hongming Zhu, Xiaoyang Li, Yunxiang Zhang, Zhen Jin, Zi-Zhen Xu, Junmin Li
Publikováno v:
Annals of Hematology. 97:1327-1335
CD19 chimeric antigen receptor (CAR) T cell therapy has shown impressive results in treating acute lymphoblastic leukemia (B-ALL), chronic lymphoblastic leukemia (B-CLL), and B-cell non-Hodgkin lymphoma (B-NHL) over the past few years. Meanwhile, the